Heart attack cell therapy under Long-Term safety watch
NCT ID NCT07400458
First seen Feb 11, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study follows 100 people who had a heart attack and received a cell therapy called Hearticellgram-AMI. Researchers want to see if there are any long-term safety issues, such as death, new cancers, or immune system problems. Participants are simply observed over time to track these risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KIMHYUNSOO Clinic
RECRUITINGSeoul, Gangnam, 06017, South Korea
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.